NVDA vs. LRCX: Which AI Semiconductor Stock Is the Better Buy?

The article favors NVIDIA over Lam Research, citing NVIDIA's fiscal Q2 2027 revenue growth of 106% to $96.22 billion, 75% gross margin and forward P/E of 15.18 versus Lam Research's 23.02. Lam reported fiscal Q1 2027 revenue growth of 54.4% to $8.22 billion and stronger year-to-date share gains of 33.4% versus NVIDIA's 13.8%; NVIDIA's Q3 revenue guidance is $108 billion, plus or minus 2%. Supply limits, rising memory costs and China-related uncertainty pose risks for NVIDIA, while equipment-output constraints and changing China sales weigh on Lam's near-term outlook. Zacks rates NVIDIA #1 (Strong Buy) and Lam Research #3 (Hold).

Analysis

The key distinction is demand exposure versus the ability to monetize it: NVIDIA captures AI spending when compute is deployed, while Lam Research benefits earlier in the manufacturing-capacity chain. Near-term tool constraints can therefore defer Lam’s revenue without disproving demand, while NVIDIA’s own supply and memory-cost limits can convert a strong backlog into slower shipments and margin dilution. If deployment budgets remain firm, those bottlenecks are more likely to shift revenue timing than eliminate it; a spending pause would hurt both, but could hit equipment orders with greater cyclicality.

The headline valuation comparison is not yet a sufficient basis for a pair trade. Verify that the forward P/E figures use comparable fiscal periods, earnings definitions, and current estimates; a low multiple may reflect unusually high near-term earnings or risk assumptions rather than mispricing. Lam also offers a less direct bet on any single AI-chip winner, but its China exposure and sensitivity to fab spending make it vulnerable to export restrictions and capex deferrals. Applied Materials and KLA are relevant equipment peers for checking whether Lam-specific execution or a broader WFE cycle is driving revisions.

Over days, positioning and results revisions may dominate. Over 1–3 months, watch shipment constraints, gross-margin progression, China mix, and whether equipment guidance converts into orders. Over 6–18 months, the thesis depends on sustained AI infrastructure budgets and capacity additions. Contrarian angle: slower sequential growth at Lam may be a supply/clean-room timing issue, not a demand signal; conversely, NVIDIA’s apparent relative-value case can fail if margins disappoint or growth expectations reset.

Key Decisions for Investors

• Prefer a measured long-NVIDIA/short-Lam Research relative-value position only after verifying comparable forward earnings inputs. Keep sizing modest: the pair is exposed to semiconductor-factor moves and can lose if AI deployment delays hurt NVIDIA while equipment orders remain resilient.
• For a cleaner expression, consider adding NVIDIA on weakness only while shipment growth and gross margin remain consistent with management’s stated path; do not chase solely on the article’s valuation comparison.
• Treat Lam Research as a watch rather than an outright short: look for order or systems-revenue estimate cuts beyond stated capacity constraints, and compare revisions with Applied Materials and KLA before concluding the issue is company-specific.
• Falsify the NVIDIA preference if reported margins fall materially below the guided range, data-center growth decelerates alongside weaker customer spending, or comparable forward valuation proves higher after estimate reconciliation. Reassess Lam if China-related weakness or fab-capacity delays persist into subsequent guidance.